ArticleHuman vaccines & immunotherapeutics2025
Knowledge, attitudes, and willingness towards HPV vaccine among male college students in Zhejiang Province, China.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess HPV-related knowledge and willingness to receive the HPV vaccine among male college students in Zhejiang Province, and to identify influencing factors to provide an evidence-based foundation for vaccination promotion. We conducted a questionnaire survey on male college students in Zhejiang Province, Sociodemographic data, an HPV-knowledge scale, and items measuring vaccine awareness and willingness were collected. Guided by the Health Belief Model (HBM) and a stigma scale, six dimensions were evaluated: perceived susceptibility, severity, benefits, barriers, self-efficacy, and a stigma index. Among 604 participants (mean age 19.33 ± 1.39 years), 67.1% (n = 405) were willing to receive the HPV vaccine. Compared with unwilling students, willing students scored higher on HPV knowledge (5.05 ± 1.73 vs 3.78 ± 2.43,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.